Eloxx Pharmaceuticals, Inc.

ELOX·NasdaqCM
Compare
13.89+0.15 (+1.09%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close13.74
Open14.01
Day range13.8214.62
52-week range8.2023.40
Off day high−4.99%
Off 52-week high−40.64%
Volume26.00K
Avg. volume (3M)44.69K
Market cap56.07M
EPS (TTM)3.52
Forward P/E-19.56
P/E ratio (TTM)3.95
Dividend yield—
Beta (5Y)—
Shares outstanding4.04M
Short interest—
Earnings dateApr 2, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ELOX PRQR EDSA ATYR TOVX ELDN
Market cap 56.07M 228.61M 39.72M 21.07M 10.07M 198.28M
P/E (TTM) 3.9 — — — 0.3 —
Forward P/E -19.6 -3.4 — -0.5 -1.1 -3.2
Price/book 1.2 2.6 71.7 0.4 0.8 2.7
Dividend yield — — — — — —
1-year change +24.80% −28.82% +38.19% −74.53% −51.11% −8.82%
Today +1.09% −0.61% −16.24% −12.75% +1.11% −1.61%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ELOX news ›
Markets Daily·Positive

Eloxx Pharmaceuticals (ELOX) and Its Rivals Critical Comparison

Posted by Kim Johansen on Oct 1st, 2026 Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) is one of 902 public companies in the “Pharmaceuticals” industry, but how does it contrast to its rivals? We will compare Eloxx Pharmaceuticals…

MarketBeat·

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Short Interest Update

Get Our Latest Stock Report on Eloxx Pharmaceuticals Eloxx Pharmaceuticals (NASDAQ:ELOX - Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($0.66) earnings per share for the quarter.…

From articles in the 4Search news index.

In the news

11mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.